drugset / Trial / NCT03976700

Bufei Jianpi Granule for Delaying Pulmonary Function Decline in Early-Stage COPD

NCT03976700

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to establish the treatment scheme of Bufei Jianpi granule for early-stage (GOLD stage 1 or 2) chronic obstructive pulmonary disease (COPD), delaying pulmonary function decline and forming high quality evidence.

Timeline

Start
2019-06
Primary completion
2021-06
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bufeijianpi granule Traditional medicine (herbal / TCM)